BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol 2014; 6(5): 104-111 [PMID: 24834140 DOI: 10.4251/wjgo.v6.i5.104]
URL: https://www.wjgnet.com/1948-5204/full/v6/i5/104.htm
Number Citing Articles
1
Eric Freund, Kim Rouven Liedtke, Julia van der Linde, Hans-Robert Metelmann, Claus-Dieter Heidecke, Lars-Ivo Partecke, Sander Bekeschus. Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivoScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37169-3
2
Jorja Braden, Prunella Blinman, Ashanya Malalasekera, Kim Kerin-Ayres, Jarrah Spencer, Natalie Southi, Janette L. Vardy. The utility of surveillance CT scans in a cohort of survivors of colorectal cancerJournal of Cancer Survivorship 2023; 17(4): 1202 doi: 10.1007/s11764-021-01155-y
3
Sara Khor, Eric C. Haupt, Erin E. Hahn, Lindsay Joe L. Lyons, Veena Shankaran, Aasthaa Bansal. Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as PredictorsJAMA Network Open 2023; 6(6): e2318495 doi: 10.1001/jamanetworkopen.2023.18495
4
Eric Freund, Kim-Rouven Liedtke, Lea Miebach, Kristian Wende, Amanda Heidecke, Nagendra Kumar Kaushik, Eun Ha Choi, Lars-Ivo Partecke, Sander Bekeschus. Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells In vitroCancers 2020; 12(1): 122 doi: 10.3390/cancers12010122
5
Shibnath Ghatak, Vincent C. Hascall, Nikos Karamanos, Roger R. Markwald, Suniti Misra. Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistanceFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.906260
6
Shibnath Ghatak, Vincent C. Hascall, Roger R. Markwald, Suniti Misra. HyaluronanBiology of Extracellular Matrix 2023; 14: 119 doi: 10.1007/978-3-031-30300-5_7
7
Allison Y. Ye, Winson Y. Cheung, Karen J. Goddard, Daniel Horvat, Robert A. Olson. Follow-up patterns of cancer survivors: a survey of Canadian radiation oncologistsJournal of Cancer Survivorship 2015; 9(3): 388 doi: 10.1007/s11764-014-0390-2
8
Mark Jeffery, Brigid E Hickey, Phillip N Hider. Follow-up strategies for patients treated for non-metastatic colorectal cancerCochrane Database of Systematic Reviews 2019; 2019(9) doi: 10.1002/14651858.CD002200.pub4
9
Linda Aagaard Rasmussen, Henry Jensen, Line Flytkjær Virgilsen, Alina Zalounina Falborg, Henrik Møller, Peter Vedsted. Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register studyBMC Health Services Research 2019; 19(1) doi: 10.1186/s12913-019-4757-y
10
Benjamin Allaire, Robbie Skinner, Grant King, Amanda Honeycutt, Dominick Esposito. An economic evaluation of reducing colorectal cancer surveillance intensityJournal of Comparative Effectiveness Research 2022; 11(2): 99 doi: 10.2217/cer-2021-0065
11
Sharlene Gill, Jeffrey A. Meyerhardt, Monica Arun, Christine M. Veenstra. Translating IDEA to Practice and Beyond: Managing Stage II and III Colon CancerAmerican Society of Clinical Oncology Educational Book 2019; (39): 226 doi: 10.1200/EDBK_237443
12
Eric Freund, Kim Rouven Liedtke, Rebecca Gebbe, Amanda Kathleen Heidecke, Lars-Ivo Partecke, Sander Bekeschus. In Vitro Anticancer Efficacy of Six Different Clinically Approved Types of Liquids Exposed to Physical PlasmaIEEE Transactions on Radiation and Plasma Medical Sciences 2019; 3(5): 588 doi: 10.1109/TRPMS.2019.2902015
13
Knut Magne Augestad, Marianne A Merok, Dejan Ignatovic. Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic ConsiderationsClinical Medicine Insights: Oncology 2017; 11: 117955491769076 doi: 10.1177/1179554917690766
14
Mark Jeffery, Brigid E Hickey, Phil N Hider, Adrienne M See. Follow-up strategies for patients treated for non-metastatic colorectal cancerCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD002200.pub3
15
Min Young Park, In Ja Park, Hyo Seon Ryu, Jay Jung, Minsung Kim, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim. Optimal postoperative surveillance strategies for stage III colorectal cancerWorld Journal of Gastrointestinal Surgery 2021; 13(9): 1012-1024 doi: 10.4240/wjgs.v13.i9.1012
16
Michele M. Gage, Matthew T. Hueman. Colorectal Cancer Surveillance: What Is the Optimal Frequency of Follow-up and Which Tools Best Predict Recurrence?Current Colorectal Cancer Reports 2017; 13(4): 316 doi: 10.1007/s11888-017-0382-5